Current research on STX16 primarily focuses on its role in pseudohypoparathyroidism (PHP), particularly PHP1b, in which STX16 deletions are implicated in abnormal methylation of the GNAS locus, leading to endocrine resistance. This evidence concerns the gene STX16 and pseudohypoparathyroidism.